Cardiac Surgical Product Adoption Survey
Survey analysis reveals important learnings from a February 2020 HFMA-conducted study, sponsored by Edwards Lifesciences, about cardiac surgical product adoption.
Factors that Influence Cardiac Surgical Technology Purchases
A visual analysis of a February 2020 HFMA survey about factors that influence cardiac surgical technology decisions.
Survey: Hospitals overspending on corporate services could reduce costs without impacting quality
Important learnings from a November 2019 HFMA-conducted survey about corporate services spending patterns and how organizations could be more efficient and effective with their spend.
New ‘terms and conditions’ added for providers accepting latest round of CARES funding
Hospitals will have additional terms and conditions with which to comply if they accept a share of $20 billion in new federal assistance.
Mandatory bundled payment program for joint replacement makes changes to accommodate hospitals during COVID-19
Medicare’s largest mandatory bundled payment program is striving to adapt to the unique challenges the coronavirus has created for its hospital participants.
Medicare suspends COVID-19 advance payments for Part B providers
Medicare has suspended access to advance payments for Part B providers during the COVID-19 pandemic.
The end of the beginning: Outgoing HFMA Chair looks ahead
Healthcare finance leaders should not view the COVID-19 crisis as an ending to what has gone before. Instead, they should see what's happening today as a time for renewal and regeneration.
COVID-19 is the deflection point for new health system flexibility
Integrated health systems will require flexibility as they begin a process of adjusting to the new healthcare environment that follows the COVID-19 crisis.
8 hallmarks of a successful healthcare venture capital program
Health systems that are developing venture capital projects should apply eight core principles that reflect best practices of organizations that had a strong track record of success in managing their venture capital programs.
Congress approves $75 billion in additional COVID-19 relief for providers
President Trump signed legislation April 24 to add $75 billion to provider relief related to the effects of the coronavirus.